Nicotine replacement therapy … - Carlos A ... - Entretiens du Carla

Conclusions
With contributions
from:
P. Bartsch, G. Lagrue,
S. Nardini, J. Perriot
Introduction
Tobacco use is the leading cause of premature
mortality in the world and is responsible
for a very high morbidity rate. This addictive
behavior is a chronic and relapsing disorder,
reinforced by a physical dependence attributable
mainly to nicotine. This dependence
evolves over a number of years, often marked
by attempts to quit and relapses.
Regardless of the strategy selected to stop
smoking, psycho-behavioral support, medical
treatment and follow-up over time must be
made available as they increase the chances
of the patient’s potential success in quitting
and reduce the risk of relapses.
The choice of drugs is based on the patient’s
medical history, the risk of adverse effects, the
degree of dependence, related comorbidities,
the existence of potential contraindications
and user precautions, potential risks of drug
dependence and misuse, the patient’s preferences
and the cost of the therapy.
This consensus of experts has the task to
draw up proposals so as to standardize Indications
and Contraindications of Nicotine
Replacement Therapies. This involves reduction
in consumption, temporary cessation,
increase in the dose prescribed and the ability
to combine 2 NRTs , NRTs in persons under the
age of 18, contraindications: pregnancy,
cardiovascular diseases.
6
From left to right,
D. Thomas,
J. Perriot,
J-M. Pibourdin,
I. Berlin,
F. Van Bladeren
(slightly hidden),
I. Vadasz,
R. Rusu,
P.V. Pataka,
H. Martino,
N. Saïchi.